GM

Glenn Miller

PT Point Therapeutics: 7 patents #2 of 5Top 40%
BI Biogen: 4 patents #26 of 174Top 15%
📍 Haverhill, MA: #16 of 285 inventorsTop 6%
🗺 Massachusetts: #11,548 of 88,656 inventorsTop 15%
Overall (All Time): #470,073 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
7282484 Anti-tumor agents Barbara P. Wallner 2007-10-16
7259138 Anti-tumor agents Barbara P. Wallner 2007-08-21
7067489 Hematopoietic stimulation Barbara P. Wallner, Barry Jones, Sharlene Adams 2006-06-27
6949514 Anti-tumor agents Barbara P. Wallner 2005-09-27
6890904 Anti-tumor agents Barbara P. Wallner 2005-05-10
6770628 Hematopoietic stimulation Barbara P. Wallner, Barry Jones, Sharlene Adams 2004-08-03
6300314 Hematopoietic stimulation Barbara P. Wallner, Barry Jones, Sharlene Adams 2001-10-09
5928643 Method of using CD2-binding domain of lymphocyte function associated antigen 3 to initiate T cell activation Barbara P. Wallner, Margaret D. Rosa 1999-07-27
5914111 CD2-binding domain of lymphocyte function associated antigen-3 Barbara P. Wallner, Margaret D. Rosa 1999-06-22
5728677 Methods of inhibiting T-cell dependent proliferation of peripheral blood lymphocytes using the CD2-binding domain of lymphocyte function associated antigen 3 Barbara P. Wallner, Margaret D. Rosa 1998-03-17
5547853 CD2-binding domain of lymphocyte function associated antigen 3 Barbara P. Wallner, Margaret D. Rosa 1996-08-20